Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Movement Disorders (revue) - Exploration (Accueil)

Index « Mesh.i » - entrée « Substance Withdrawal Syndrome »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Substance P < Substance Withdrawal Syndrome < Substance-Related Disorders  Facettes :

List of bibliographic references indexed by Substance Withdrawal Syndrome

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
001A30 (2010) Mohammed T. Ahmad [Singapour] ; Kumar M. Prakash [Singapour]Reversible hyperkinetic movement disorder associated with quetiapine withdrawal
001D73 (2010) Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward
002D03 (2007) David Epstein [États-Unis] ; Marc Difazio [États-Unis]Orofacial automatisms induced by acute withdrawal from high‐dose midazolam mimicking nonconvulsive status epilepticus in a child
003157 (2006) Hortensia Alonso-Navarro [Espagne] ; Félix Javier Jiménez-Jiménez [Espagne]Tardive blepharospasm beginning after withdrawal of veralipride
003165 (2006) Anna De Rosa [Italie] ; Pasquale Striano [Italie] ; Fabrizio Barbieri [Italie] ; Arturo De Falco [Italie] ; Carlo Rinaldi [Italie] ; Tecla Tucci [Italie] ; Salvatore Striano [Italie] ; Alessandro Filla [Italie] ; Giuseppe De Michele [Italie]Suppression of myoclonus in SCA2 by piracetam
003166 (2006) Vicky L. Marshall [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP‐CIT SPECT
003306 (2006) Matthew A. Brodsky [États-Unis] ; Penelope Hogarth [États-Unis] ; John G. Nutt [États-Unis]OFF–off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease
003512 (2006) Claudia Trenkwalder [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Andreas Kupsch [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Juergen Koester [Allemagne] ; Juergen Reess [Allemagne]Controlled withdrawal of pramipexole after 6 months of open‐label treatment in patients with restless legs syndrome
003543 (2006) Kazumasa Suzuki [Japon] ; Shuichi Awata [Japon] ; Kae Nakagawa [Japon] ; Takehisa Takano [Japon] ; Hiroo Matsuoka [Japon]Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy
003563 (2006) Julian P. Rodrigues [Australie] ; Dylan J. Edwards [Australie] ; Susan E. Walters [Australie] ; Michelle L. Byrnes [Australie] ; Gary W. Thickbroom [Australie] ; Rick Stell [Australie] ; Frank L. Mastaglia [Australie]Blinded placebo crossover study of gabapentin in primary orthostatic tremor
003746 (2005) Costas Michaelides [États-Unis] ; Manisha Thakore-James [États-Unis] ; Raymon Durso [États-Unis]Reversible withdrawal dyskinesia associated with quetiapine
003992 (2005) Shafeeq S. Ladha [États-Unis] ; Russell Walker [États-Unis] ; Holly A. Shill [États-Unis]Case of neuroleptic malignant‐like syndrome precipitated by abrupt fava bean discontinuance
003A33 (2005) Astrid Thomas [Italie] ; Marco Onofrj [Italie]Akinetic crisis, acute akinesia, neuroleptic malignant‐like syndrome, Parkinsonism–hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal
004534 (2002) Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra [États-Unis] ; Robert A. Hauser [États-Unis]Clozapine withdrawal symptoms in a Parkinson's disease patient
004742 (2001) P. H. Gordon [États-Unis] ; S. J. Frucht [États-Unis]Neuroleptic malignant syndrome in advanced Parkinson's disease
004933 (2000) Robert A. Hauser [États-Unis] ; William C. Koller [États-Unis] ; Jean P. Hubble [États-Unis] ; Teresita Malapira [États-Unis] ; Karen Busenbark [États-Unis] ; C. Warren Olanow [États-Unis]Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease
004A45 (2000) Doron Merims [Israël] ; Ronit Galili-Mosberg [Israël] ; Eldad Melamed [Israël]Is there addiction to levodopa in patients with Parkinson's disease?
004C42 (1999) A. Churchyard [Royaume-Uni] ; C. J. Mathias [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Selegiline‐induced postural hypotension in Parkinson's disease: A longitudinal study on the effects of drug withdrawal
004D12 (1999) Nir Giladi [Israël] ; H. Shabtai [Israël]Melatonin‐induced withdrawal emergent dyskinesia and akathisia
004F44 (1998) Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Nicotine nasal spray is not reliable treatment for blepharospasm: Results of a pilot study
005055 (1998) José F. Martí-Mass [Espagne] ; Juan J. Poza [Espagne]Cinnarizine‐induced parkinsonism: Ten years later

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Substance Withdrawal Syndrome" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Substance Withdrawal Syndrome" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Substance Withdrawal Syndrome
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024